Esteban Velarde

2.2k total citations · 1 hit paper
29 papers, 991 citations indexed

About

Esteban Velarde is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Esteban Velarde has authored 29 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Oncology and 6 papers in Genetics. Recurrent topics in Esteban Velarde's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers) and Glioma Diagnosis and Treatment (6 papers). Esteban Velarde is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers) and Glioma Diagnosis and Treatment (6 papers). Esteban Velarde collaborates with scholars based in United States, China and Mexico. Esteban Velarde's co-authors include Thomas R. Nirschl, Charles G. Drake, Christina M. Kochel, Christopher J. Nirschl, Andrew B. Sharabi, Theodore L. DeWeese, Brian J. Francica, Debebe Theodros, Ali Ghasemzadeh and Juan Salvatierra and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Cancer Research.

In The Last Decade

Esteban Velarde

28 papers receiving 975 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen

2014 510 citations Andrew B. Sharabi, Christopher J. Nirschl et al. Cancer Immunology Research profile →

Peers

Esteban Velarde

ONCOL

IMMUN

PRM

RNMI

Eva‐Maria Weiss Germany

Burles A. Johnson United States

Rénata Ursu France

Shayan Fakurnejad United States

Yasmeen Sarfraz United States

Jean‐Christophe Brisset United States

Robert Cavaliere United States

Verena von Felbert Germany

Philipp Karschnia Germany

Sapna Devi Australia

Eva‐Maria Weiss Germany

Esteban Velarde

303 ×0.5

ONCOL

359 ×0.9

IMMUN

130 ×0.6

PRM

223 ×1.8

106 ×0.9

RNMI

Citations per year, relative to Esteban Velarde Esteban Velarde (= 1×) peers Eva‐Maria Weiss

Countries citing papers authored by Esteban Velarde

Since Specialization

Citations

This map shows the geographic impact of Esteban Velarde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esteban Velarde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esteban Velarde more than expected).

Fields of papers citing papers by Esteban Velarde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esteban Velarde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esteban Velarde. The network helps show where Esteban Velarde may publish in the future.

Co-authorship network of co-authors of Esteban Velarde

This figure shows the co-authorship network connecting the top 25 collaborators of Esteban Velarde. A scholar is included among the top collaborators of Esteban Velarde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esteban Velarde. Esteban Velarde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Velarde, Esteban, et al.. (2025). Developing Magnetic Resonance Imaging Biomarkers of Neuroinflammation, Cognitive Impairment, and Survival Outcomes for Radiotherapy-Induced Brain Injury in a Preclinical Mouse Model. Investigative Radiology. 61(1). 10–25.

Appidi, Tejaswini, Michèle Moreau, Esteban Velarde, et al.. (2025). Engineered multifunctional nanoparticles for enhanced radiation therapy: three-in-one approach for cancer treatment. Molecular Cancer. 24(1). 68–68. 7 indexed citations

Slika, Hasan, Sadia Rahman, Vrashabh V. Sugandhi, et al.. (2024). Intracranial Nanogel Pellets Carrying Temozolomide and Paclitaxel for Adjuvant Brain Cancer Therapy. Molecular Pharmaceutics. 22(1). 131–141. 3 indexed citations

Lam, Brandon, John C. Lin, Claire Y.‐H. Huang, et al.. (2023). In situ vaccination via tissue-targeted cDC1 expansion enhances the immunogenicity of chemoradiation and immunotherapy. Journal of Clinical Investigation. 134(1). 12 indexed citations

Liatsou, Ioanna, Anders Josefsson, Jing Yu, et al.. (2022). Bone Marrow Relative Biological Effectiveness for a 212Pb-labeled Anti-HER2/neu Antibody. International Journal of Radiation Oncology*Biology*Physics. 115(2). 518–528. 3 indexed citations

Lin, Brian L., Joseph Shin, Nadan Wang, et al.. (2022). Pharmacological TRPC6 inhibition improves survival and muscle function in mice with Duchenne muscular dystrophy. JCI Insight. 7(19). 15 indexed citations

Chu, Chengyan, Catherine M. Davis, Xiaoyan Lan, et al.. (2020). Neuroinflammation After Stereotactic Radiosurgery-Induced Brain Tumor Disintegration Is Linked to Persistent Cognitive Decline in a Mouse Model of Metastatic Disease. International Journal of Radiation Oncology*Biology*Physics. 108(3). 745–757. 11 indexed citations

Oei, Arlene L., Preethi Korangath, Kathleen R. Mulka, et al.. (2019). Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer. International Journal of Hyperthermia. 36(sup1). 47–63. 46 indexed citations

Woodard, Lauren E., Cindi L. Dennis, J. A. Borchers, et al.. (2018). Nanoparticle architecture preserves magnetic properties during coating to enable robust multi-modal functionality. Scientific Reports. 8(1). 12706–12706. 18 indexed citations

10.

Muroyama, Yuki, Thomas R. Nirschl, Christina M. Kochel, et al.. (2017). Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment. Cancer Immunology Research. 5(11). 992–1004. 166 indexed citations

11.

Sarabia-Estrada, Rachel, Sagar Shah, Abdul-Kareem Ahmed, et al.. (2017). Effects of primary and recurrent sacral chordoma on the motor and nociceptive function of hindlimbs in rats: an orthotopic spine model. Journal of Neurosurgery Spine. 27(2). 215–226. 8 indexed citations

12.

Muroyama, Yuki, Thomas R. Nirschl, Christina M. Kochel, et al.. (2017). Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment. The Journal of Immunology. 198(Supplement_1). 204.19–204.19. 5 indexed citations

13.

Yang, Chen, Dong‐Hoon Lee, Antonella Mangraviti, et al.. (2015). Quantitative correlational study of microbubble‐enhanced ultrasound imaging and magnetic resonance imaging of glioma and early response to radiotherapy in a rat model. Medical Physics. 42(8). 4762–4772. 12 indexed citations

14.

Patel, Mira, Jennifer Kim, Debebe Theodros, et al.. (2015). Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma. Journal for ImmunoTherapy of Cancer. 3(S2). 5 indexed citations

15.

Sharabi, Andrew B., Christopher J. Nirschl, Christina M. Kochel, et al.. (2014). Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen. Cancer Immunology Research. 3(4). 345–355. 510 indexed citations breakdown →

16.

Baía, Gilson S., Jessica Ho, Esteban Velarde, et al.. (2014). Preclinical evaluation of the combination of mTOR and proteasome inhibitors with radiotherapy in malignant peripheral nerve sheath tumors. Journal of Neuro-Oncology. 118(1). 83–92. 11 indexed citations

17.

Lee, Daniel A., Sooyeon Yoo, Thomas Pak, et al.. (2014). Dietary and sex-specific factors regulate hypothalamic neurogenesis in young adult mice. Frontiers in Neuroscience. 8. 157–157. 71 indexed citations

18.

Sharabi, Andrew B., Christopher J. Nirschl, Thomas R. Nirschl, et al.. (2014). Role of Radiation Therapy in Inducing Antigen Specific Antitumor Immune Responses When Combined With Anti-PD1 Checkpoint Blockade: Mechanism and Clinical Implications. International Journal of Radiation Oncology*Biology*Physics. 90(1). S1–S1. 7 indexed citations

19.

Lee, Daniel A., Juan Salvatierra, Esteban Velarde, et al.. (2013). Functional Interrogation of Adult Hypothalamic Neurogenesis with Focal Radiological Inhibition. Journal of Visualized Experiments. e50716–e50716. 7 indexed citations

20.

Velarde, Esteban, et al.. (1993). Cryptosporidium sp in 300 children with and without diarrhea.. PubMed. 22(3-4). 329–32. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact